Vimarsana
Biggest News Aggregation in the World

Effective Barrier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Effective Barrier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Effective Barrier Today - Breaking & Trending Today

Thermoform Packaging Market to Worth USD 88.50 Billion By - Vimarsana News

Thermoform Packaging Market to Worth USD 88.50 Billion By

Key companies covered in the Thermoform Packaging Market are Huhtamaki Oyj (Finland), AFG Packaging (Italy), CJK Packaging (U.S.), Amcor Plc (Switzerland),...

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection - Vimarsana News

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection - Vimarsana News

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection - Vimarsana News

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

NP-003 study terminated early with high significance in reducing viral infection. TEL AVIV , Israel, Nov. 24, 2021 /PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical

Nasus Pharma Announces Data Demonstrating In Vitro Efficacy of Taffix Intranasal Antiviral Spray Against SARS-CoV-2 British and South African Variants - Vimarsana News

Nasus Pharma Announces Data Demonstrating In Vitro Efficacy of Taffix Intranasal Antiviral Spray Against SARS-CoV-2 British and South African Variants

(0) TEL AVIV, Israel, April 21, 2021 /PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address acute medical conditions and public health threats, today announced data from a collaborative in vitro study with the Central Virology Laboratory, Ministry of Health, Public Health Services, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel, which demonstrated that the gel layer produced by Taffix powder after administration of a tissue culture infectious dose of the virus, effectively blocked 1...